Maning, Merlin .
HRN: 16-57-07 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/18/2026
CEFTAZIDIME 1GM (VIAL)
03/18/2026
03/25/2026
IV
1 Gm
Q 6h
DM Foot, Left
Checking Initial Appropriateness
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines